Global vaccine equity demands reparative justice — not charity
Open Access
- 21 June 2021
- journal article
- editorial
- Published by BMJ in BMJ Global Health
- Vol. 6 (6) , e006504
Abstract
By late April, more than 80% of the world’s COVID-19 vaccines had gone to people in wealthy countries, with just 0.3% to people in low-income countries.1 This reprehensible imbalance is no accident. High-income countries have used neocolonial negotiating power, global policy leverage and capital to procure enough doses to cover 245% of their citizens while leaving few doses for poorer countries.2 As a result, lower-income countries may not be able to vaccinate their populations until 2023.3Keywords
Funding Information
- FIC (D43 TW010543)
- Leverhulme Trust
- NIAID (K08 AI139361, R01 GM130900)
This publication has 7 references indexed in Scilit:
- Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort studyThe Lancet, 2021
- Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemicPLOS Medicine, 2021
- What it will take to vaccinate the world against COVID-19Nature, 2021
- Epidemic Illusions2020
- Compulsory licensing of pharmaceuticals reconsidered: Current situation and implications for access to medicinesGlobal Public Health, 2017
- Decolonizing Post-Colonial Studies and Paradigms of Political-Economy: Transmodernity, Decolonial Thinking, and Global ColonialityTRANSMODERNITY: Journal of Peripheral Cultural Production of the Luso-Hispanic World, 2011
- The Development of UnderdevelopmentMonthly Review, 1966